SNWV
SANUWAVE Health, Inc.Company Information
- Company Name
- SANUWAVE Health, Inc.
- CIK
- CIK0001417663
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SNWV: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SNWV
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-10-06
- Last sale
- 2026-05-01
- Shares purchased (TTM)
- 1,267
- Shares sold (TTM)
- 64,394
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,199,280
- Shares outstanding
- 8,601,198
- Ownership
- 37.20%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -22.08%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Nonrelated Party | - | - | - | - | - | - | 0 | 1 | 4 | - | 5 | - | ||||||
| Related Party | - | - | - | - | - | - | 0 | 1 | 4 | - | 5 | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 9 | 11 | 12 | 10 | 8 | 9 | 10 | 3 | 2 | 3 | 2 | 1 | ||||||
| Accounts Receivable Net Current | 6 | 6 | 5 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Inventory Net | 7 | 6 | 6 | 7 | 6 | 5 | 4 | 3 | 3 | 2 | 3 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 2 | 2 | 1 | ||||||
| Assets Current | 23 | 24 | 25 | 23 | 20 | 19 | 18 | 10 | 9 | 11 | 10 | 7 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 0 | 0 | 1 | 0 | 0 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | ||||||
| Goodwill | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Deferred Finance Costs Noncurrent Net | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Assets Noncurrent | 13 | 13 | 13 | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | ||||||
| Assets | 37 | 37 | 37 | 36 | 33 | 31 | 30 | 22 | 21 | 23 | 22 | 20 | ||||||
Liabilities Current | ||||||||||||||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | 8 | 6 | - | 7 | - | ||||||
| Other Notes Payable | - | - | - | - | - | - | - | 1 | 1 | - | - | - | ||||||
| Secured Debt Current | 6 | 6 | 6 | 6 | - | - | 0 | - | - | - | - | - | ||||||
| Senior Notes Current | - | - | 0 | 0 | 27 | 26 | 25 | 24 | 23 | 19 | 18 | 18 | ||||||
| Accounts Payable Current | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | ||||||
| Accrued Liabilities Current | 9 | 9 | 8 | 4 | 3 | 4 | 8 | 5 | 5 | 7 | 6 | 6 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Finance Lease Liability Current | - | - | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Interest Payable Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 5 | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Liabilities Current | 18 | 18 | 18 | 20 | 47 | 47 | 45 | 82 | 60 | 70 | 65 | 85 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Secured Long Term Debt | 13 | 14 | 16 | 17 | - | - | 0 | - | - | - | - | - | ||||||
| Line Of Credit | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Finance Lease Liability Noncurrent | - | - | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 16 | 17 | 18 | 19 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 34 | 35 | 36 | 39 | 48 | 48 | 46 | 82 | 61 | 71 | 66 | 86 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | ||||||
| Additional Paid In Capital | 248 | 246 | 244 | 243 | 241 | 240 | 239 | 178 | 177 | 176 | 177 | 171 | ||||||
| Retained Earnings Accumulated Deficit | -245 | -244 | -243 | -246 | -256 | -257 | -254 | -239 | -218 | -225 | -220 | -238 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | ||||||
| Stockholders Equity | 3 | 2 | 2 | -3 | -19 | -21 | -16 | -60 | -40 | -48 | -43 | -66 | ||||||
| Liabilities And Stockholders Equity | 37 | 37 | 37 | 36 | 33 | 31 | 30 | 22 | 21 | 23 | 22 | 20 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Series B Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Series C Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Series D Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Subsequent Event | - | - | - | - | - | - | - | 5 | - | - | - | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | ||||||
| Common Stock Shares Issued | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 3 | 1,181 | 1,141 | 3 | 1,026 | ||||||
| Shares Outstanding | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 3 | 1,181 | 1,141 | 3 | 1,026 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSANUWAVE Health, Inc. (SNWV) — SEC Financial Statements & Analysis
SANUWAVE Health, Inc. (SNWV) is a surgical & medical instruments & apparatus company, incorporated in NV. SANUWAVE Health, Inc. trades on Nasdaq as: SNWV. SANUWAVE Health, Inc. (SNWV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, SANUWAVE Health, Inc. carries a market cap of $86.01M, a P/E ratio of 5.64x, a P/B ratio of 30.86x, a P/S ratio of 1.95x, an enterprise value of $95.16M, and an EV/EBITDA multiple of 35.31x. On profitability, it posts a gross margin of 76.33%, an operating margin of 3.41%, a net margin of 34.66%, a Return on Equity (ROE) of -190.59%, and a Return on Assets (ROA) of 43.82%. Per share, it reports EPS of $1.77, diluted EPS of $1.77, free cash flow per share of $0.49, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 12.67% year-over-year, net income growth of -137.51% year-over-year, and EPS growth of -137.33% year-over-year. On the balance sheet, it maintains a current ratio of 1.28x, a quick ratio of 0.84x, working capital of $5.03M, a debt-to-equity ratio of 12.13x, a debt ratio of 0.92, an interest coverage ratio of 0.43x, free cash flow of $4.24M (TTM), and net debt of $9.14M. Figures sourced from SEC EDGAR.
- Market Cap
- $86.01M
- P/E TTM
- 5.64x
- EPS TTM
- $1.77
- P/B TTM
- 30.86x
- ROE TTM
- -190.59%
- ROA TTM
- 43.82%
- Debt To Equity
- 12.13x
- Free Cash Flow TTM
- $4.24M
- Net Revenue TTM Growth 1Y
- 12.67%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SANUWAVE Health, Inc. in?
SANUWAVE Health, Inc. (SNWV) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SNWV trade on?
SANUWAVE Health, Inc. (SNWV) trades on the Nasdaq.
Where is SANUWAVE Health, Inc. incorporated?
SANUWAVE Health, Inc. is incorporated in NV.
When was SANUWAVE Health, Inc. (SNWV)'s most recent SEC filing?
SANUWAVE Health, Inc. (SNWV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is SNWV's market cap?
SANUWAVE Health, Inc. (SNWV) has a market capitalization of $86.01M as of 2026-06-30.
What is SNWV's P/E ratio?
SANUWAVE Health, Inc. (SNWV)'s trailing twelve month P/E ratio is 5.64x as of 2026-06-30.
What is SNWV's EPS (earnings per share)?
SANUWAVE Health, Inc. (SNWV)'s trailing twelve month EPS is $1.77 as of 2026-06-30.
What is SNWV's ROE (return on equity)?
SANUWAVE Health, Inc. (SNWV)'s trailing twelve month Return on Equity (ROE) is -190.59% as of 2026-06-30.
What is SNWV's ROA (return on assets)?
SANUWAVE Health, Inc. (SNWV)'s trailing twelve month Return on Assets (ROA) is 43.82% as of 2026-06-30.
What is SNWV's EV/EBITDA?
SANUWAVE Health, Inc. (SNWV)'s trailing twelve month EV/EBITDA is 35.31x as of 2026-06-30.